Research and Practice Development Director ANTT, The Association for Safe Aseptic Practice.
Clinical Director ANTT, The Association for Safe Aseptic Practice.
Br J Nurs. 2021 Jan 14;30(1):8-14. doi: 10.12968/bjon.2021.30.1.8.
This article discusses the importance of effective skin antisepsis prior to the insertion of peripheral intravenous catheters (PIVCs) and how best clinical practice is promoted by application of an appropriate method of skin disinfection integrated effectively with a proprietary aseptic non touch technique, or other standard aseptic technique. Historically under-reported, incidence of infection and risk to patients from PIVCs is now increasingly being recognised, with new research and evidence raising concern and helping to drive new clinical guidance and improvement. The risks posed by PIVCs are particularly significant given increasing PIVC dwell times, due to cannula removal now being determined by new guidance for clinical indication, rather than predefined time frames. Clinical 'best practice' is considered in context of the evidence base, importantly including availability and access to appropriate skin antisepsis products. In the UK, and other countries, ChloraPrep is the only skin antisepsis applicator licensed as a drug to disinfect skin and help prevent infections before invasive medical procedures, such as injections, blood sampling, insertion of PIVCs and minor or major surgery.
本文讨论了在插入外周静脉导管 (PIVC) 之前进行有效皮肤消毒的重要性,以及如何通过应用适当的皮肤消毒方法并与专有无菌非接触技术或其他标准无菌技术有效结合,最好地促进临床实践。历史上报告不足的 PIVC 感染发生率和对患者的风险现在越来越受到关注,新的研究和证据引起了关注,并有助于推动新的临床指导和改进。鉴于留置时间的增加,PIVC 带来的风险尤其显著,因为现在根据临床指征而不是预定义的时间框架来决定是否去除导管。在考虑到证据基础的情况下,临床“最佳实践”被认为是重要的,包括获得适当的皮肤消毒剂产品的可用性和可及性。在英国和其他国家,氯己定洗必泰是唯一一种被许可作为药物使用的皮肤消毒剂,用于在侵入性医疗程序(如注射、采血、插入 PIVC 和小手术或大手术)前消毒皮肤并帮助预防感染。